According to the report, the global biomarkers market size was valued at $46.4 billion in 2023, and is projected to reach $134.2 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
Biomarkers are measurable indicators that serve as objectifiable and quantifiable signs of biological processes, disease states, or responses to therapeutic interventions within an organism. They play a crucial role in the field of healthcare, such as in aiding in disease diagnosis, prognosis, and monitoring treatment efficacy. Moreover, biomarkers facilitate the development and evaluation of new drugs and therapies by enabling researchers to measure their impact on biological systems.
Key Takeaways
- By type, the sample preparation segment held the largest share in the biomarkers market in 2022. However, the efficacy biomarkers segment is expected to register the highest growth during the forecast period.
- By application, the drug discovery and development segment held the largest biomarkers market share in 2022. However, the disease diagnosis segment is expected to register the highest growth during the forecast period.
- By service, sample preparation segment held the largest share in the biomarkers market analysis in 2022. However, the assay development segment is expected to register the highest growth during the forecast period.
- Region-wise, North America held the largest market share in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period.
Request Sample of the Report – https://www.alliedmarketresearch.com/press-release/biomarker-market.html
Market Dynamics
Factors that drive the growth of the biomarkers market size include a rise in geriatric population and surge in demand for companion diagnostics. Technological advancements in the field of biomarkers have emerged as a major driver for the biomarkers market share. According to the World Health Organization, it was estimated that by 2030, 1 in 6 people in the world are expected to be aged 60 years or over.
As the geriatric population is on the rise globally, there is a heightened demand for effective diagnostic and prognostic tools to address the complex healthcare needs of this aging demographic. Biomarkers, which are measurable indicators of biological processes or conditions, play a crucial role in the early detection, monitoring, and management of various age-related diseases such as cardiovascular disorders, neurodegenerative conditions, and certain types of cancers.
The elderly often exhibit a higher susceptibility to chronic ailments, necessitating precision medicine approaches for personalized healthcare. Biomarkers offer a non-invasive means of assessing disease risk, progression, and response to treatment, enabling healthcare practitioners to tailor interventions on the basis of individual patient profiles. The rise in geriatric population makes age-related illnesses more common and highlights the need for creative and specific healthcare solutions. Thus, the rise in geriatric population is expected to drive the growth of the market.
Market Segmentation:
The biomarkers market can be segmented based on various criteria, including:
Type of Biomarker:
Protein Biomarkers
Genetic Biomarkers (DNA, RNA, microRNA)
Metabolic Biomarkers
Imaging Biomarkers
Cellular Biomarkers
Other Biomarkers (e.g., epigenetic biomarkers, circulating tumor cells)
Application:
Disease Diagnosis (e.g., cancer, cardiovascular diseases, neurological disorders)
Drug Discovery and Development
Personalized Medicine
Risk Assessment and Prediction
Prognostic and Predictive Biomarkers
Therapeutic Monitoring
Other Applications (e.g., environmental monitoring, agriculture)
End User:
Hospitals and Clinics
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Other End Users
Technology:
Immunoassays (ELISA, Western blotting, multiplex assays)
Molecular Assays (PCR, next-generation sequencing)
Imaging Technologies (PET, MRI, CT)
Mass Spectrometry
Flow Cytometry
Other Technologies
Disease Area:
Oncology
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Autoimmune Disorders
Metabolic Disorders
Other Disease Areas
Geography:
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Key Player Analysis:
F. Hoffmann-La Roche AG
Revvity, Inc.
Qiagen N.V
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc.
Siemens AG
Merck KGaA
GE Healthcare
Agilent Technologies Inc.
Abbott Laboratories
On the basis of service, the sample preparation segment generated maximum revenue in 2022 owing to the growing emphasis on personalized medicine and precision diagnostics has spurred the development of innovative sample preparation technologies tailored to specific biomarker applications and patient populations. However, the assay development segment is expected to register highest CAGR owing to the fact that as understanding of disease mechanisms and molecular pathways deepens, there is a growing demand for sophisticated and highly specific assays capable of detecting and quantifying biomarkers with exceptional sensitivity and accuracy.
Region-wise, the North America region generated the highest revenue in 2022, owing to the strong presence of key players, well-developed healthcare infrastructure, and rise in geriatric population. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to a rise in prevalence of chronic diseases and surge in research initiatives by companies in the region.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biomarkers market analysis from 2023 to 2033 to identify the prevailing biomarkers market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the biomarkers market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global biomarkers industry trends, key players, market segments, application areas, and market growth strategies.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2024?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2033?
- Which region has more opportunities?
You may Also Like
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
